

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuv...
Q2 2026
Aug 6, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 5, 2026
Q4 2025
Mar 5, 2026
Q3 2025
Nov 12, 2025